Oligodynamic Effect of Silver Nanoparticles: a Review

被引：39
作者：
Prasher P. [1 ]
Singh M. [1 ]
Mudila H. [2 ]
机构：
[1] Department of Chemistry, University of Petroleum & Energy Studies, Dehradun
[2] Department of Chemistry, Lovely Professional University, Jalandhar, 144411, Punjab
来源：
BioNanoScience | 2018年 / 8卷 / 04期
关键词：
Multidrug resistance; Silver nanoparticles;
D O I：
10.1007/s12668-018-0552-1
中图分类号：
学科分类号：
摘要：
The advent, efficacy, followed by the undiscerning and unrestricted consumption of antibiotics resulted in undue evolution in microbes in the form of multidrug resistance eventually resulting in the cultivation of new challenges to develop the new-generation antimicrobial therapy. A critical need for the development of novel, broad-spectrum therapeutics has thus arrived. The Silver nanoparticles (AgNPs) over the last few years have gained immense reputation as the next-generation antibiotics owing to their broad-spectrum activity against the disease-causing microbes which has been also extended against the highly evolved MDR strains. Also known to support the synergistic effect in combination with various commercially used antibiotics, the potential of AgNPs could be extensively exploited to gradually replace the old-generation drugs that certainly have lost their tooth against the resistant microbes. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码：951 / 962
页数：11
相关论文
共 159 条
[1]  
Izadpanah M., Khalili H., Antibiotic regimens for treatment of infections due to multidrug-resistant gram-negative pathogens: an evidence-based literature review, Journal of Research in Pharmacy Practice, 4, pp. 105-114, (2015)
[2]  
Ventola C.L., The antibiotic resistance crisis part 1: causes and threats, Pharmacy and Therapeutics, 40, pp. 277-283, (2015)
[3]  
Fair R.J., Tor Y., Antibiotics and bacterial resistance in the 21st century, Perspectives in Medicinal Chemistry, 6, pp. 25-64, (2014)
[4]  
Zaccheo A., Palmaccio E., Venable M., Locarnini-Sciaroni I., Parisi S., Biocides and “Superbugs”, Food Hygiene and Applied Food Microbiology in an Anthropological Cross Cultural Perspective, pp. 63-72, (2016)
[5]  
Friedman N.D., Temkin E., Carmeli Y., The negative impacts of antibiotic resistance, Clinical Microbiology and Infection, 22, pp. 416-422, (2016)
[6]  
Karam G., Chastre J., Wilcox M.H., Vincent J.-L., Antibiotic strategies in the era of multidrug resistance, Critical Care, 20, (2016)
[7]  
Chung-Delgado K., Guillen-Bravo S., Revilla-Montag A., Bernabe-Ortiz A., Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors, PLoS One, 10, (2015)
[8]  
Jeon D.S., Shin D.O., Park S.K., Seo J.E., Seo H.S., Cho Y.S., Lee J.Y., Kim D.Y., Kong S.J., Ki Y.S., Shim T.S., Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector, Journal of Korean Medical Science, 26, pp. 33-41, (2011)
[9]  
Schnippel K., Rosen S., Shearer K., Martinson N., Long L., Sanne I., Variava E., Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa, Tropical Medicine & International Health, 18, pp. 109-116, (2013)
[10]  
Tiong J.J.L., Loo J.S.E., Mai C.-W., Global antimicrobial stewardship: a closer look at the formidable implementation challenges front, Microbiol, 7, (2016)
12345678910